These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 3568657

  • 1. The effect of oral contraceptives on hormone profiles of oligomenorrheic adolescent cycles.
    Siegberg R, Nilsson CG, Stenman UH, Widholm O.
    Contraception; 1987 Jan; 35(1):29-40. PubMed ID: 3568657
    [Abstract] [Full Text] [Related]

  • 2. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
    Siegberg R, Nilsson CG, Stenman UH, Widholm O.
    Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
    [Abstract] [Full Text] [Related]

  • 3. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
    Nappi C, Farace MJ, Leone F, Minutolo M, Tommaselli AP, Montemagno U.
    Eur J Obstet Gynecol Reprod Biol; 1987 Jul; 25(3):209-19. PubMed ID: 2956138
    [Abstract] [Full Text] [Related]

  • 4. Endocrinologic features of oligomenorrheic adolescent girls.
    Siegberg R, Nilsson CG, Stenman UH, Widholm O.
    Fertil Steril; 1986 Nov; 46(5):852-7. PubMed ID: 3096784
    [Abstract] [Full Text] [Related]

  • 5. Effects of combined ethinylestradiol and desogestrel on hormone profiles and sex hormone binding globulin in women with polycystic ovarian disease.
    Rojanasakul A, Sirimongkolkasem R, Piromsawasdi S, Sumavong V, Chailurkit L, Chaturachinda K.
    Contraception; 1987 Dec; 36(6):633-40. PubMed ID: 2965636
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K, Lunell NO, Zador G.
    Gynecol Obstet Invest; 1978 Dec; 9(6):304-11. PubMed ID: 754992
    [Abstract] [Full Text] [Related]

  • 7. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A, Dewailly SD, Grenier R, Huard J.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [Abstract] [Full Text] [Related]

  • 8. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T, Reymond M, Rappoport G, Magrini G, Gomez J.
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [Abstract] [Full Text] [Related]

  • 9. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ, Slaats EH, Kennedy JC, de Vries Robles-Korsen TJ, Schoemaker J.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [Abstract] [Full Text] [Related]

  • 10. Elevation of serum prolactin during application of oral contraceptives.
    Dericks-Tan JS, Taubert HD.
    Contraception; 1976 Jul; 14(1):1-8. PubMed ID: 975808
    [No Abstract] [Full Text] [Related]

  • 11. Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle.
    Moller SE, Moller BM, Olesen M, Fjalland B.
    Eur J Clin Pharmacol; 1996 Jul; 50(3):179-84. PubMed ID: 8737756
    [Abstract] [Full Text] [Related]

  • 12. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M, Almström E, Högstedt S, Nabrink M.
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [Abstract] [Full Text] [Related]

  • 13. Menstruation-related periodic hypersomnia: a case study with successful treatment.
    Sachs C, Persson HE, Hagenfeldt K.
    Neurology; 1982 Dec; 32(12):1376-9. PubMed ID: 6890644
    [Abstract] [Full Text] [Related]

  • 14. Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LH-RH+.
    Dericks-Tan JS, Krög W, Aktories K, Taubert HD.
    Contraception; 1976 Aug; 14(2):171-81. PubMed ID: 780050
    [No Abstract] [Full Text] [Related]

  • 15. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V, Weiner E, Victor A, Johansson ED.
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [Abstract] [Full Text] [Related]

  • 16. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM, Tiitinen A, Stenman UH, Seppälä M, Laatikainen T.
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [Abstract] [Full Text] [Related]

  • 17. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW, de la Peña A, Chenault CB, Cervantes A.
    Am J Obstet Gynecol; 1975 Jul 01; 122(5):625-36. PubMed ID: 1146928
    [Abstract] [Full Text] [Related]

  • 18. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD.
    Fertil Steril; 1996 Jul 01; 66(1):101-4. PubMed ID: 8752618
    [Abstract] [Full Text] [Related]

  • 19. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R, Reinilä M, Kivinén S.
    Acta Derm Venereol; 1986 Jul 01; 66(3):225-30. PubMed ID: 2426899
    [Abstract] [Full Text] [Related]

  • 20. Fasting serum growth hormone levels and growth hormone responses to exercise during normal menstrual cycles and cycles of oral contraceptives.
    Hansen AP, Weeke J.
    Scand J Clin Lab Invest; 1974 Nov 01; 34(3):199-205. PubMed ID: 4428162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.